Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $134.05 USD
Change Today +0.30 / 0.22%
Volume 1.2M
As of 5:20 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Jeffrey M. Leiden M.D., Ph.D.

Chairman, Chief Executive Officer and President,Vertex Pharmaceuticals Incorporated
AgeTotal Calculated CompensationThis person is connected to 137 board members in 6 different organizations across 10 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Jeffrey M. Leiden, also known as Jeff, M.D., Ph.D. has been the Chairman of Vertex Pharmaceuticals Incorporated since May 2012 and has been its Chief Executive Officer and President since February 1, 2012. He is a Senior Advisor at Clarus Ventures, LLC. Dr. Leiden has more than 20 years of scientific, commercial and financial experience in the pharmaceutical and biotechnology industries as well as clinical and scientific experience in academia as a practicing cardiologist ...

Read Full Background

Corporate Headquarters*

50 Northern Avenue
Boston, Massachusetts 02210

United States

Phone: 617-341-6100
Fax: --

Board Members Memberships*

Member of Executive Committee of Board of Trustees
Chairman, Chief Executive Officer and President
Director and Member of Compensation Committee


Harvard University
The University of Chicago
The University of Chicago
The University of Chicago

Other Affiliations*

Annual Compensation*

Total Annual Compensation$1,100,000

Stock Options*

Restricted Stock Awards$19,883,350
All Other Compensation$12,857
Exercised Options245,000
Exercised Options Value$18,793,100
Exercisable Options396,294
Exercisable Options Value$27,918,929
Unexercisable Options611,841
Unexercisable Options Value$33,090,777
Total Value of Options$79,802,806
Total Number of Options1,253,135

Total Compensation*

Total Annual Cash Compensation$4,082,857
Total Short Term Compensation$1,100,000
Other Long Term Compensation$19,896,207
Total Calculated Compensation$36,635,468
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRTX:US $134.05 USD +0.30


Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
Jean-Jacques Bienaime MBAChairman and Chief Executive Officer
BioMarin Pharmaceutical Inc.
Rakesh Sachdev Chief Executive Officer, President and Director
Sigma-Aldrich Corporation
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERTEX PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at